Pasteurization of Mother's Own Milk for Preterm Infants
1 other identifier
interventional
303
1 country
1
Brief Summary
We hypothesize that short term infection-related benefits of human milk feeding are decreased by the process of pasteurization. Primary objective of the study is to compare the incidence of late-onset sepsis in very low birth weight infants assigned randomly to receive either pasteurized or raw expressed mothers'own milk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable sepsis
Started Mar 2006
Longer than P75 for not_applicable sepsis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 18, 2012
CompletedFirst Posted
Study publicly available on registry
April 19, 2012
CompletedDecember 6, 2023
November 1, 2023
3.9 years
April 18, 2012
November 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of late-onset sepsis
the incidence of proven late-onset sepsis, occurring more than 48 hours after birth, with growth of a pathogen or coagulase-negative staphylococci (CoNS) cultured from blood, obtained from a peripheral vein under aseptic conditions, combined with the acute onset of two or more predefined clinical signs and, only in case of growth of a CoNS isolate, at least one laboratory parameter of systemic infection (such as elevated C-reactive protein, left shift or leukopenia).
up to 8 weeks of age
Secondary Outcomes (1)
necrotizing enterocolitis
up to 8 weeks of age
Study Arms (2)
raw milk
NO INTERVENTIONInfants who were assigned to the raw group received fresh or thawed milk from their own mother, cultured weekly with a semi-quantitative analysis. Raw milk was withheld if it contained any Gram-negative organisms, S. aureus or enterococci.
pasteurized milk
ACTIVE COMPARATORInfants who were assigned to pasteurization received own mother's milk heat treated at 62,5°C for 30 minutes with a Sterifeed® S75 TES pasteurizer.
Interventions
mother's milk heat treated at 62,5°C for 30 minutes with a Sterifeed® S75 TES pasteurizer.
Eligibility Criteria
You may qualify if:
- all patients born before 32 weeks of gestational age and/or with BW below 1500 g admitted to the tertiary NICU of the University Hospitals Leuven within 24 hours of birth
You may not qualify if:
- died within 24 hours after birth
- no consent
- admitted after 24 hours of birth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospitals
Leuven, 3000, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Veerle Cossey, Dr
Universitaire Ziekenhuizen KU Leuven
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prinicpal Investigator
Study Record Dates
First Submitted
April 18, 2012
First Posted
April 19, 2012
Study Start
March 1, 2006
Primary Completion
February 1, 2010
Study Completion
April 1, 2012
Last Updated
December 6, 2023
Record last verified: 2023-11